Premenstrual Dysphoric Disorder Completed Phase Trials for Levetiracetam (DB01202)

Also known as: Premenstrual dysphoric disorder

IndicationStatusPhase
DBCOND0005024 (Premenstrual Dysphoric Disorder)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00518570Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)Treatment